SCHEMBL1844156

SCHEMBL1844156

OCC1OC(O)CS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318062 1.00
SCHEMBL5430730 1.00
SCHEMBL6318074 1.00
SCHEMBL5430740 1.00
SCHEMBL13254105 0.73
SCHEMBL8995817 0.73
SCHEMBL5021290 0.73
SCHEMBL13632904 0.73
SCHEMBL13430314 0.73
SCHEMBL9556755 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10995075-B2 Process for producing fluorocytosine and fluorocytosine derivatives UNIVERSITY OF DURHAM 2021-05-04 US claimed
CN-106795123-B Fluorocytosine and fluorocytosine derivatives 杜伦大学 2021-03-16 CN claimed
US-20200095207-A1 Process for Producing Fluorocytosine and Fluorocytosine Derivatives UNIVERSITY OF DURHAM (GB) 2020-03-26 US claimed
EP-3186231-B1 PROCESS FOR PRODUCING FLUOROCYTOSINE AND FLUOROCYTOSINE DERIVATIVES UNIV DURHAM (GB) 2019-07-10 EP claimed
US-20170298028-A1 Process for Producing Fluorocytosine and Fluorocytosine Derivatives UNIVERSITY OF DURHAM (GB) 2017-10-19 US claimed
EP-3186231-A1 PROCESS FOR PRODUCING FLUOROCYTOSINE AND FLUOROCYTOSINE DERIVATIVES University of Durham (GB) 2017-07-05 EP claimed
CN-106795123-A Fluorocytosine and fluorocytosine derivatives 杜伦大学 2017-05-31 CN claimed
WO-2016030662-A1 PROCESS FOR PRODUCING FLUOROCYTOSINE AND FLUOROCYTOSINE DERIVATIVES UNIVERSITY OF DURHAM (GB) 2016-03-03 WO claimed
US-6903224-B2 Substituted 1,3-oxathiolanes BIOCHEM PHARMA INC. (CA) 2005-06-07 US claimed
US-20030087918-A1 Synthesis of substituted 1,3-dioxolanes and substituted 1,3-oxathiolanes with antiviral properties BIOCHEM PHARMA INC. (CA) 2003-05-08 US claimed
US-10995075-B2 Process for producing fluorocytosine and fluorocytosine derivatives UNIVERSITY OF DURHAM 2021-05-04 US disclosed
CN-106795123-B Fluorocytosine and fluorocytosine derivatives 杜伦大学 2021-03-16 CN disclosed
US-20200095207-A1 Process for Producing Fluorocytosine and Fluorocytosine Derivatives UNIVERSITY OF DURHAM (GB) 2020-03-26 US disclosed
EP-3186231-B1 PROCESS FOR PRODUCING FLUOROCYTOSINE AND FLUOROCYTOSINE DERIVATIVES UNIV DURHAM (GB) 2019-07-10 EP disclosed
US-20170298028-A1 Process for Producing Fluorocytosine and Fluorocytosine Derivatives UNIVERSITY OF DURHAM (GB) 2017-10-19 US disclosed
US-6518425-B1 A process for producing a 1,3-oxathiolane nucleoside comprising reacting a 5-halo-2-protected-oxymethyl-1,3-oxathiolane with a silylated purine or pyrimidine without the addition of a Lewis acid or an additional base to the reaction EMORY UNIVERSITY 2003-02-11 US disclosed
US-6350753-B1 2-ACETOXYMETHYL-4-(THYMIN-1'-YL)-1,3,-DIOXOLANE; 2-BENZOYLOXYMETHYL-4-(CYTOSIN-1'-YL)-1,3-DIOXOLANE; ANTIVIRAL AGENTS, PARTICULARY FOR THE TREATMENT OF THE HIV INFECTIONS IN MAMMALS, ESPECIALLY HUMANS BIOCHEM PHARMA INC. (CA) 2002-02-26 US disclosed
EP-1104415-A1 METHOD OF MANUFACTURE OF 1,3-OXATHIOLANE NUCLEOSIDES Triangle Pharmaceuticals Inc. (US) 2001-06-06 EP disclosed
US-6215004-B1 CYCLIZATION OF MERCAPTOACETIC ACID WITH ACETAL IN SOLVENT; SULFIDING EMORY UNIVERSITY 2001-04-10 US disclosed
WO-2000009494-A1 METHOD OF MANUFACTURE OF 1,3-OXATHIOLANE NUCLEOSIDES TRIANGLE PHARMACEUTICALS, INC. (US) 2000-02-24 WO disclosed